Mylan Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 3/1/2020)
| Balance Sheet | Total Assets | 31,255,500,000.00 | ROE | – |
| Balance Sheet | Total Equity | 11,883,800,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -213,200,000.00 | P/FCF | – |
| Cashflow | Free Cash Flow | 1,590,500,000.00 | – | – |
| Cashflow | Operating Cash Flow | 1,803,700,000.00 | P/CF | – |
| Income | Earnings per Share (diluted) | 0.03 | Div. Yield | – |
| Income | Net Income | 16,800,000.00 | P/E | – |
| Income | Shares Outstanding | 560,000,000.00 | P/B | – |
| Income | Total Revenue | 11,500,500,000.00 | P/S | – |
Ratios calculated on: –
Company Description
Mylan Inc. (Mylan) is a fully integrated global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan has two segments:Generics and Specialty. Its generic pharmaceutical business is conducted primarily in the United States and Canada (collectively, North America); Europe, the Middle East, and Africa (collectively, EMEA); and India, Australia, Japan and New Zealand (collectively, Asia Pacific). Its API business is conducted through Mylan Laboratories Limited (Mylan India), which is included within the Asia Pacific region in its Generics Segment. The Company's pharmaceutical business is conducted by Mylan Specialty L.P. (Mylan Specialty). Mylan provides products to customers in approximately 140 countries and territories. In December 2013, In December 2013, the Company announced that it has completed the acquisition of the Agila injectables businesses from Strides Arcolab Ltd.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.mylan.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more